Table 3

Changes in amino acid metabolites in GC and EC, compared with controls

StudySample typeAnalytical platformEssential amino acidNon-essential amino acid
ValHisPheThrLeuMetTrpIleLysTyrGlnGluSerAsnGlyAlaArgAspCysPro
GC
 Tugnoli (2006)69TissueHR-MAS NMR
 Calabrese (2008)68TissueHR-MAS MRS
 Hirayama (2009)66TissueCE–MS
Wu (2010)61TissueGC–MS
Yu (2011)58PlasmaGC/TOF MS
Song (2012)51SerumGC–MS
Aa (2012)52Serum
Tissue
GC/TOFMS
Jung (2014)39Urine
Tissue
1H NMR;
HR-MAS NMR
↑↑



Chen (2014)41UrineMRB-CE-MS
Yang (2014)43SerumLC–MS
Liang (2015)37UrineLC–MS
Wang (2016)33Tissue1H NMR
Chan (2016)34Urine1H-NMR
Kuligowski (2016)35PlasmaUPLC–TOFMS
Wang (2017)31SerumHPLCESI/Q-TOFMS
Lario (2017)25PlasmaLC–MS
Xiu (2018)20PlasmaUHPLC–MS/MS
Jing (2018)23PlasmaLC–MS/MS
EC
Wu (2009)67TissueGC/MS
Yakoub (2010)62TissueNMR
Ayshamgul (2010)65Plasma1H NMR
Zhang (2011)60SerumNMR
Zhang (2012)54SerumLC–MS and NMR
Hasim (2012)53Urine
Plasma
1H NMR
Davis (2012)55Urine1H NMR
Ikeda (2012)50SerumGC–MS
Yang (2013)45Tissue1H NMR
Zhang (2013)46Serum1H NMR; UHPLC
Wang (2013)48Tissue1H NMR
Xu (2016)36UrineLC–MS
Zhang (2017)26TissueLC–MS
Cheng (2017)27SerumUPLC-MS/MS
Cheng (2017)28SerumLC-MS/MS
Zhu (2017)29Serum
Tissue
GC/TOF-MS















Reed (2017)30Tissue1H NMR
Tokunaga (2018)22TissueCE-TOFMS
Ma (2018)24Serum2D LC–MS

EO, esophageal cancer; GC, gastric cancer; Val, valine; His, histidine; Phe, phenylalanine; Thr, threonine; Leu, leucine; Met, methionine; Trp, tryptophan; Ile, isoleucine; Lys, lysine; Tyr, tyrosine; Gln, glutamine; Glu, glutamic acid; Ser, serine; Asn, asparagine; Gly, glycine; Ala, alanine; Arg, arginine; Asp, aspartic acid; Cys, cystine; Pro, proline; 1H NMR, proton nuclear magnetic resonance; HR-MAS-NMR, high-resolution magic angle spinning-nuclear magnetic resonance spectroscopy; GC–MS, gas chromatography–mass spectrometry; CE–MS, capillary electrophoresis–mass spectrometry; HPLC–MS, high-performance liquid chromatography–mass spectrometry; LC–MS, liquid chromatography–mass spectrometry